|
MechanismPotassium channel blockers |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date28 Dec 1995 |
100 Clinical Results associated with Maanshan Fengyuan Pharmaceutical Co Ltd
0 Patents (Medical) associated with Maanshan Fengyuan Pharmaceutical Co Ltd
100 Deals associated with Maanshan Fengyuan Pharmaceutical Co Ltd
100 Translational Medicine associated with Maanshan Fengyuan Pharmaceutical Co Ltd